empty
05.02.2025 12:44 AM
Pfizer Stock Rises: Why Now is the Best Time to Trade?

On Tuesday, shares of Pfizer Inc. rose by 1.7% in pre-market trading following the release of its Q4 2024 financial report, which exceeded analysts' expectations.

The American pharmaceutical giant reported a net profit of $410 million, or 7 cents per share. This represents a significant improvement compared to a loss of $3.37 billion, or 60 cents per share, during the same period last year.

The company's revenue increased by 22%, totaling $17.76 billion, compared to $14.57 billion in Q4 2023. This performance surpassed FactSet's consensus estimate of $17.35 billion.

This image is no longer relevant

This growth is primarily due to a one-time non-cash revenue return of $3.5 billion associated with its antiviral drug Paxlovid. Additionally, there has been an increase in sales from the Seagen oncology portfolio, the Vyndaqel family for cardiovascular treatment, and overall growth in Paxlovid sales.

Total sales of Paxlovid reached $727 million, a significant improvement compared to the $3.14 billion loss recorded last year, which stemmed from the transition to a traditional commercial sales model in the U.S.

Furthermore, Pfizer experienced a positive impact from currency fluctuations, which added an extra $62 million to its overall revenue. The company's management has reaffirmed its forecast for 2025, projecting revenue between $61 billion and $64 billion, with adjusted earnings per share ranging from $2.80 to $3.00.

According to FactSet, the average analyst expectations are for revenue of $63.07 billion and earnings of $2.91 per share.

Pfizer's CFO, David Denton, expressed confidence that the company will return to pre-pandemic operational margin levels in the coming years and achieve total cost savings of $4.5 billion by the end of 2025.

This situation presents several opportunities for traders. Pfizer's stock has risen following a strong earnings report, which may indicate a continuation of this upward trend, making the company's shares attractive for short- and medium-term speculative trades.

Furthermore, considering the company's long-term prospects in innovative drug development, Pfizer remains a promising asset for investors seeking stable capital growth.

Access to Pfizer shares and other leading global companies is available through the InstaForex trading platform.

Fast order execution, a wide range of instruments including CFDs on U.S. stocks, and no deposit restrictions enable traders to respond swiftly to market changes.

The availability of leverage up to 1:1000 and low commissions also provides additional opportunities for effective capital management.

Given the high volatility in the pharmaceutical sector and the upcoming release of key data on drug sales, investors should monitor Pfizer's stock closely.

In the upcoming quarters, the company is expected to continue growing its revenue by expanding its portfolio of prescription drugs, which could lead to further increases in its share prices.

Ekaterina Kiseleva,
Analytical expert of InstaForex
© 2007-2025
Summary
Urgency
Analytic
Ekaterina Kiseleva
Start trade
Earn on cryptocurrency rate changes with InstaForex
Download MetaTrader 4 and open your first trade
  • Grand Choice
    Contest by
    InstaForex
    InstaForex always strives to help you
    fulfill your biggest dreams.
    JOIN CONTEST

Recommended Stories

Markets on edge: Trump targets EU, inflation and China data in focus

Wall Street and European equity indices opened the week in the red, following losses across Asian markets on Monday. Investors are reacting to the latest bout of trade war rhetoric

14:48 2025-07-14 UTC+2

US Market News Digest for July 14

Donald Trump announced 30% tariffs on goods from the EU and Mexico. The initial market reaction was negative, but the S&P 500 partially rebounded thanks to gains in large-cap stocks

Ekaterina Kiseleva 14:36 2025-07-14 UTC+2

Markets on edge: Trump vs. EU, inflation and China data ahead

Wall Street futures and European shares dipped during Monday's Asian session as investors responded to renewed tariff threats from the United States. Despite the aggressive tone, many still believe President

Thomas Frank 10:40 2025-07-14 UTC+2

Stock Boom: Nvidia Crosses $4 Trillion, Bitcoin Not Lagging Behind, Dow and S&P Rising

Indices Rising: Dow Jones Up 0.43%, S&P 500 Up 0.27%, Nasdaq Up 0.09% Nvdia Ends Trading with Historical Valuation, Exceeding $4 Trillion Delta Positive Outlook Stimulates Aviation and Transport Sectors

Thomas Frank 08:37 2025-07-11 UTC+2

Nvidia Makes History: Market Rising, Company Capitalization Breaks $4 Trillion Ceiling

Indices Up: Dow Jones — 0.49%, S&P 500 — 0.61%, Nasdaq — 0.95% Nvidia Is the First Company to Reach $4 Trillion in Market Value AES Jumps on Sale Attempts

Thomas Frank 10:46 2025-07-10 UTC+2

US Market News Digest for July 9

US stock indices closed the session with modest moves: the S&P 500 edged slightly lower, the Nasdaq 100 posted a mild gain, and the Dow Jones slipped into negative territory

Ekaterina Kiseleva 14:03 2025-07-09 UTC+2

Trump Back in Action: 50% Copper Tariff, More Blows to China, EU

Trump Announces 50% Copper Tariff Announces New Tariffs on Semiconductors, Pharmaceuticals President Trump Says Talks with EU, China Are Making Progress Japan, South Korea Work Hard to Minimize Tariff Damage

Thomas Frank 09:49 2025-07-09 UTC+2

US Market News Digest for July 8

The US stock market shows restrained momentum amid uncertainty over Donald Trump's potential return to high tariffs. Although the US president has expressed a willingness to negotiate, market participants

Ekaterina Kiseleva 12:08 2025-07-08 UTC+2

Trade storm over Asia: Japan, Korea face 25% tariff hit

Japan, South Korea face 25% tariffs by Aug. 1 Australian dollar rises as RBA keeps rates on hold The pan-European STOXX 600 index (.STOXX) was unchanged at 543.22

Thomas Frank 10:52 2025-07-08 UTC+2

Canceled deals, fresh letters – marching toward trade chaos? Trader's calendar for June 7-9

Symbolically, it was on July 4, Independence Day, that Donald Trump signed what he himself called the "Big Beautiful Bill," which, according to the White House, will "fulfill campaign promises."

Svetlana Radchenko 14:07 2025-07-07 UTC+2
Can't speak right now?
Ask your question in the chat.
Widget callback
 

Dear visitor,

Your IP address shows that you are currently located in the USA. If you are a resident of the United States, you are prohibited from using the services of InstaFintech Group including online trading, online transfers, deposit/withdrawal of funds, etc.

If you think you are seeing this message by mistake and your location is not the US, kindly proceed to the website. Otherwise, you must leave the website in order to comply with government restrictions.

Why does your IP address show your location as the USA?

  • - you are using a VPN provided by a hosting company based in the United States;
  • - your IP does not have proper WHOIS records;
  • - an error occurred in the WHOIS geolocation database.

Please confirm whether you are a US resident or not by clicking the relevant button below. If you choose the wrong option, being a US resident, you will not be able to open an account with InstaForex anyway.

We are sorry for any inconvenience caused by this message.